Sponsor
Nearly 20% of cancer drugs defective in 4 African nations
A recent study reveals a concerning prevalence of substandard cancer drugs in several African nations, including Ethiopia, Kenya, Malawi, and Cameroon. Approximately 17% of tested medications had incorrect active ingredient levels, potentially hindering treatment effectiveness and leading to disease progression. Experts emphasize the urgent need for improved regulation, screening technologies,...
0 Reacties 0 aandelen 105 Views 0 voorbeeld